An outbreak caused by the SARS-CoV-2 Delta variant (B.1.617.2) in a secondary care hospital in Finland, May 2021-Reference-Cited by-同舟云学术

An outbreak caused by the SARS-CoV-2 Delta variant (B.1.617.2) in a secondary care hospital in Finland, May 2021

Published:2021-07-29 Issue:30 Volume:26 Page:
ISSN:1560-7917
Container-title:Eurosurveillance
language:en
Short-container-title:

Author:

Hetemäki Iivo¹²,Kääriäinen Sohvi³⁴,Alho Pirjo²,Mikkola Janne²,Savolainen-Kopra Carita³,Ikonen Niina³,Nohynek Hanna³,Lyytikäinen Outi³

Affiliation:

1. Translational Immunology Program, Helsinki University and Helsinki University Central Hospital, Helsinki, Finland

2. Infectious Diseases Unit, Kanta-Häme Central Hospital, Hämeenlinna, Finland

3. Finnish Institute for Health and Welfare, Helsinki, Finland

4. ECDC Fellowship Programme, Field Epidemiology path (EPIET), European Centre for Disease Prevention and Control, (ECDC), Stockholm, Sweden

Abstract

An outbreak caused by the SARS-CoV-2 Delta variant (B.1.617.2) spread from one inpatient in a secondary care hospital to three primary care facilities, resulting in 58 infections including 18 deaths in patients and 45 infections in healthcare workers (HCW). Only one of the deceased cases was fully vaccinated. Transmission occurred despite the use of personal protective equipment by the HCW, as advised in national guidelines, and a high two-dose COVID-19 vaccination coverage among permanent staff members in the COVID-19 cohort ward.

Publisher

European Centre for Disease Control and Prevention (ECDC)

Subject

Virology,Public Health, Environmental and Occupational Health,Epidemiology

Reference15 articles.

1. European Centre for Disease Prevention and Control (ECDC). Threat Assessment Brief: Implications for the EU/EEA on the spread of the SARS-CoV-2 Delta (B.1.617.2) variant of concern. Stockholm: ECDC; 2021. Available from: https://www.ecdc.europa.eu/en/publications-data/threat-assessment-emergence-and-impact-sars-cov-2-delta-variant

2. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England.;Davies;Science,2021

3. Ferguson NMB. 1.617.2 transmission in England: risk factors and transmission advantage. London: Imperial College London; 2021. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/993159/S1270_IMPERIAL_B.1.617.2.pdf

4. Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020.;Leung;Euro Surveill,2021

5. GISAID: Global initiative on sharing all influenza data - from vision to reality.;Shu;Euro Surveill,2017

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of nosocomial coronavirus disease 2019: comparison between single- and multiple-occupancy rooms;Antimicrobial Resistance & Infection Control;2024-08-30

2. The burden and dynamics of hospital-acquired SARS-CoV-2 in England;Nature;2023-10-18

3. Whole-genome sequencing to investigate transmission of SARS-CoV-2 in the acute healthcare setting: a systematic review;Journal of Hospital Infection;2023-10

4. Impact of supplementary air filtration on aerosols and particulate matter in a UK hospital ward: a case study;Journal of Hospital Infection;2023-05

5. Transmission and Risk Factors of COVID-19 among Health Care Workers;Seminars in Respiratory and Critical Care Medicine;2023-04-04